W
WAVEMAN · COMPANY
UHS · Universal Health Services Inc
> Ask across nine datasets ⌘K
LIVE
TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475
← ALL COMPANIES

UHS

UNIVERSAL HEALTH SERVICES INC
HEALTHCARE SERVICES · SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC · CIK 0000352915
CONGRESS · 1☆ WATCH
INSIDER NET · 180D
-$128.1K
open-market buys minus sells, Form 4 codes P and S
INSIDER BUYERS · 180D
0
CONGRESS BUYERS · 1Y
1
FUNDS ADDED · QTR
0
13F, latest reported quarter
REVENUE GROWTH
+9.7%
XBRL, annual
NET MARGIN
8.6%
CONVERSIONS · 180D
9
codes C/M, not in net · $46.9M priced
SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST
INSIDERS
net -$128.1K over 180 days
more than 66% of Healthcare Services
CONGRESS
1 member bought in the last year
the lowest in Healthcare Services
FUNDS
fewer than five institutions report holding it
REVENUE
+9.7% year over year
below 55% of Healthcare Services
MARGIN
8.6% net margin
more than 82% of Healthcare Services
BUYBACKS
$484.6M repurchased, FY to 2026-06-30
more than 94% of Healthcare Services
SHORT
no short interest reported
THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET
1 member of Congress reported buying it this year.
The year, with the filings on it
Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail
TOTAL 12M RETURN -7.4%
-7.4%12M
-22%-3%+16%+35%2025-092025-102025-122026-032026-052026-072026-09 2025-11-11 · Nimetz Warren J. sold $820.6K2025-10-29 · SUSSMAN ELLIOT J MD MBA sold $217.8K2026-03-13 · SUSSMAN ELLIOT J MD MBA sold $68.8K2026-03-11 · SUSSMAN ELLIOT J MD MBA sold $59.3K2025-11-11 · Nimetz Warren J. sold $31.8K
INSIDER SELL
INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY
Live price
Daily candles from TradingView, on their licence — no filings are marked on this one
WHY THIS NAME IS ON THE DESK
The complete filing record, in one place.
The record shows a net $128.1K sold by insiders over 180 days, 1 Congress member(s) bought in 12 months. Every figure is a federal filing, dated the day it became public.
Same sector, ranked by filing activity
Sector from the SEC's own SIC classification
Insider transactions
Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, UNIVERSAL HEALTH SERVICES INC insiders sold a net $128.1K of stock across 42 Form 4 purchases and sales, with 0 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-05.

INSIDER
FILED
SHARES
VALUE
SUSSMAN ELLIOT J MD MBA
Director
SELL
2026-03-13
356.0
$68.8K
SUSSMAN ELLIOT J MD MBA
Director
SELL
2026-03-11
318.0
$59.3K
Nimetz Warren J.
Director
SELL
2025-11-11
142.0
$31.8K
Nimetz Warren J.
Director
SELL
2025-11-11
3,675.0
$820.6K
SUSSMAN ELLIOT J MD MBA
Director
SELL
2025-10-29
965.0
$217.8K
42 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 37 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders
13F · holdings as of the latest quarter funds have reported

no 13F holders found for this ticker

SCHEDULE 13D/G
No 5%+ ownership filings
Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.
FORM 144
No planned-sale notices
No insider has notified an intent to sell. This is the panel to watch after a run-up.
Fundamentals
Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all
2025-122024-122023-122022-12
REVENUE$17.4B$15.8B$14.3B$13.4B
OPERATING INCOME$2.0B$1.7B$1.2B$1.0B
NET INCOME$1.5B$1.2B$719.3M$657.0M
EPS (DILUTED)23.1016.8210.239.14
OPERATING CASH FLOW$1.9B$2.1B$1.3B$996.0M
CASH$137.8M$126.0M$119.4M$102.8M
LONG-TERM DEBT$4.0B$4.5B$4.8B$4.7B
BUYBACKS$968.0M$670.8M$547.4M$832.9M
DIVIDENDS PAID$51.3M$53.3M$55.5M$58.4M
SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-05 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE
W WAVEMAN

Public filings, honestly analyzed. Official US government sources in one desk — every figure carries the date it was filed, and the methodology is published, backtest included.

SEC FORM 4FORM 13F 13D/GFORM 144XBRL STOCK ACTCONTRACTSFEC CFPBNRC
© 2026 WAVEMAN · SOURCE: SEC EDGAR & OFFICIAL GOVERNMENT DATA · NOT INVESTMENT ADVICE · CHART BY TRADINGVIEW · UPDATED 2026-09-05 ALL SYSTEMS LIVE FOR MACHINES →